ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Orladeyo 150 mg, Hartkapseln - 28
68464001 BioCryst Schweiz GmbH
Orladeyo 150 mg, Hartkapseln07.06.2022
  07.06.2022
Berotralstat (B06AC06) 
WHO-DDD06.06.2027
02.99.28
02.99. 
B  
Yes 
IPCI
12756.64Yes
    
10 %13334.55
  
7680684640018Synthetika
  
Composition
berotralstatum 150 mg ut berotralstati dihydrochloridum, amylum pregelificatum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 171, E 132, E 172 (nigrum), E 172 (rubrum), Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Berotralstatum150 mg
BAG: Active AgentDose
Berotralstatum150 mg
 
Inactive agents additional_information
(Nigrum)  
(Rubrum)  
Amylum Pregelificatum  
Crospovidonum  
E 132 color.
E 171 color.
E 172 color.
Gelatina Kapselhülle
Kalii Hydroxidum  
Lacca Drucktinte
Magnesii Stearas  
Pro Capsula  
Propylenglycol  
Silica Colloidalis Anhydrica  
 
Source
Data was imported : 06.07.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home